Literature DB >> 16838323

Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.

Michael Koldehoff1, Nina K Steckel, Michal Hlinka, Dietrich W Beelen, Ahmet H Elmaagacli.   

Abstract

We compared the results of chimerism analyses with real-time SNP-PCR to those obtained by the classical STR-PCR method in 135 hematopoietic stem cell transplantation recipients. Using 10 different SNP gene loci, the SNP-PCR method was able to discriminate patient from donor cells in 125 of 135 cases (93%), whereas the use of 11 different STR gene loci with the STR-PCR analysis using agarose or polyacrylamide gel resolution resulted in accurate donor-host discrimination in all patients. Of the 470 analyzed samples we found in 74% concordant results for both chimerism methods. In all 26% discordant cases the SNP-chimerism method showed mixed chimerism (MC), whereas the STR-method found complete chimerism (CC). As a consequence, the SNP-PCR chimerism analysis method detected a MC prior to the occurrence of relapse significantly earlier than the STR-PCR chimerism method (120 vs. 30 days, P < 0.007). The probability of relapses was significantly higher in patients with increasing MC (70%) compared to 30% in patients with CC (P < 0.00001) associated with a significantly shorter overall survival in patients with increasing MC. The multivariate Cox model showed that chimerism analsis with SNP-PCR was the only significant risk factor predicting relapse (RR 6.08, P < 0.0001).Furthermore, we analyzed the chimerism status in male recipients with a female donor in 580 samples of 134 patients using quantitative real-time PCR of Y-chromosome-specific sequences and compared the results with interphase XY-fluorescent in situ hybridization (FISH). MC without signs of relapse was detected in 35% of samples using quantitative real-time PCR of Y-chromosome-specific sequences. The detected Y-DNA amounts were low compared to the amounts detected in 104 samples of 42 patients with leukemic relapse at the time of analysis (P < 0.0001). Quantitative real-time PCR of Y-chromosome-specific sequences detected therefore an increasing MC with high residual host DNA amounts approximately 143 days (mean) prior to the occurrence of relapse. By comparing the results of Y-chromosome PCR with the XY-FISH analysis we found concordant results in 73% in patients with myeloablative regimens. The XY-FISH could detect 12 relapses, whereas the Y-chromosome PCR detect 36 relapses by MC (P < 0.005). Residual host cells gradually decreased during the posttransplant period from a mean of 5.4 ng (first months) to 0.5 ng (above 5 years) without evidence of relapses. The probability of relapses was significantly higher in patients with increasing MC (100%) compared to 8% in patients with CC (P < 0.00001) associated with a significantly shorter overall survival in patients with increasing MC. The multivariate Cox model showed that chimerism analysis of Y-chromosome-specific sequences is an important risk factor for relapse (RR 17.0, P < 0.0001). We conclude that the use of real-time SNP or Y-PCR may be superior to the STR-PCR or interphase XY-FISH methods in detecting patients who are at high risk for relapse after transplant.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16838323     DOI: 10.1002/ajh.20693

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  18 in total

1.  Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantation.

Authors:  Anne Bouvier; Jérémie Riou; Sylvain Thépot; Aurélien Sutra Del Galy; Sylvie François; Aline Schmidt; Corentin Orvain; Marie-Hélène Estienne; Alban Villate; Damien Luque Paz; Laurane Cottin; Bénédicte Ribourtout; Annaëlle Beucher; Yves Delneste; Norbert Ifrah; Valérie Ugo; Mathilde Hunault-Berger; Odile Blanchet
Journal:  Leukemia       Date:  2019-11-25       Impact factor: 11.528

2.  Use of killer cell immunoglobulin-like receptor genes as early markers of hematopoietic chimerism after double-umbilical cord blood transplantation.

Authors:  Pauline Rettman; Nolwenn Legrand; Catherine Willem; Laurence Lodé; Patrice Chevallier; Anne Cesbron; David Senitzer; Christelle Retière; Katia Gagne
Journal:  Haematologica       Date:  2015-07-23       Impact factor: 9.941

3.  Validation of chimerism in pediatric recipients of allogeneic hematopoietic stem cell transplantation (HSCT) a comparison between two methods: real-time PCR (qPCR) vs. variable number tandem repeats PCR (VNTR PCR).

Authors:  Morris Kletzel; Wei Huang; Marie Olszewski; Sana Khan
Journal:  Chimerism       Date:  2012-12-13

4.  Monitoring of hematopoietic chimerism by real-time quantitative PCR of micro insertions/deletions in samples with low DNA quantities.

Authors:  Christian Bach; Elmira Tomova; Katja Goldmann; Volker Weisbach; Wolf Roesler; Andreas Mackensen; Julia Winkler; Bernd M Spriewald
Journal:  Transfus Med Hemother       Date:  2014-12-22       Impact factor: 3.747

5.  Chimerism analysis in peripheral blood using indel quantitative real-time PCR is a useful tool to predict post-transplant relapse in acute leukemia.

Authors:  N Jacque; S Nguyen; J-L Golmard; M Uzunov; A Garnier; V Leblond; J-P Vernant; D Bories; N Dhédin
Journal:  Bone Marrow Transplant       Date:  2014-11-10       Impact factor: 5.483

6.  Rapid determination of chimerism status using dihydrorhodamine assay in a patient with X-linked chronic granulomatous disease following hematopoietic stem cell transplantation.

Authors:  Hyun-Young Kim; Hee-Jin Kim; Chang-Seok Ki; Dae Won Kim; Keon Hee Yoo; Eun-Suk Kang
Journal:  Ann Lab Med       Date:  2013-06-24       Impact factor: 3.464

7.  Haplotype Counting for Sensitive Chimerism Testing: Potential for Early Leukemia Relapse Detection.

Authors:  Marija Debeljak; Evelina Mocci; Max C Morrison; Aparna Pallavajjalla; Katie Beierl; Marie Amiel; Michaël Noë; Laura D Wood; Ming-Tseh Lin; Christopher D Gocke; Alison P Klein; Ephraim J Fuchs; Richard J Jones; James R Eshleman
Journal:  J Mol Diagn       Date:  2017-05       Impact factor: 5.568

8.  Quantitative chimerism: an independent acute leukemia prognosis indicator following allogeneic hematopoietic SCT.

Authors:  X-Y Qin; G-X Li; Y-Z Qin; Y Wang; F-R Wang; D-H Liu; L-P Xu; H Chen; W Han; J-Z Wang; X-H Zhang; J-L Li; L-D Li; K-Y Liu; X-J Huang
Journal:  Bone Marrow Transplant       Date:  2014-08-04       Impact factor: 5.483

9.  A Study of Human Leukocyte Antigen Mismatched Cellular Therapy (Stem Cell Microtransplantation) in High-Risk Myelodysplastic Syndrome or Transformed Acute Myelogenous Leukemia.

Authors:  Kai-Xun Hu; Qi-Yun Sun; Mei Guo; Jun-Xiao Qiao; Chang-Lin Yu; Jian-Hui Qiao; Zheng Dong; Wan-Jun Sun; Hong-Li Zuo; Ya-Jing Huang; Bo Cai; Hui-Sheng Ai
Journal:  Stem Cells Transl Med       Date:  2016-02-02       Impact factor: 6.940

10.  A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer.

Authors:  Heidi Schwarzenbach; Volkmar Müller; Cord Beeger; Miriam Gottberg; Nicole Stahmann; Klaus Pantel
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.